Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia

被引：0
|
作者：
Fava, S [1 ]
Luoni, M [1 ]
Stioui, S [1 ]
机构：
[1] LEGNANO GEN HOSP,CYTOGENET LAB,LEGNANO,ITALY
来源：
HAEMATOLOGICA | 1996年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [21] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    BLOOD, 1999, 94 (10) : 279B - 279B
  • [22] Results of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older
    Cortes, J
    Kantarjian, H
    OBrien, S
    Robertson, LE
    Pierce, S
    Talpaz, M
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (04): : 452 - 455
  • [23] MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA ON INTERFERON-ALPHA THERAPY BY QUANTITATIVE SOUTHERN BLOT
    REITER, A
    SKLADNY, H
    HOCHHAUS, A
    HEHLMANN, R
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 792 - 792
  • [24] Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia
    Maloisel, F
    Uettwiller, F
    Laplace, A
    Lioure, B
    Herbrecht, R
    Mark, M
    Dufour, P
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (02) : 172 - 176
  • [25] RESPONSE TO THE COMBINED ADMINISTRATION OF INTERFERON-ALPHA AND INTERFERON-GAMMA AFTER FAILURE OF SINGLE INTERFERON THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA
    KLOKE, O
    BECHER, R
    NIEDERLE, N
    BLUT, 1987, 55 (05): : 453 - 458
  • [26] Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia
    J Cortes
    L Fayad
    H Kantarjian
    S O’Brien
    M-S Lee
    M Talpaz
    Leukemia, 1998, 12 : 455 - 462
  • [27] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    ANSARI, H
    BLOOD, 1994, 84 (10) : A382 - A382
  • [28] Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia
    Kattan, MW
    Inoue, Y
    Giles, FJ
    Talpaz, M
    Ozer, H
    Guilhot, F
    Zuffa, E
    Huber, SL
    Beck, JR
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 541 - +
  • [29] Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia
    Cortes, J
    Fayad, L
    Kantarjian, H
    O'Brien, S
    Lee, MS
    Talpaz, M
    LEUKEMIA, 1998, 12 (04) : 455 - 462
  • [30] AUTOIMMUNE PHENOMENA ASSOCIATED WITH CUTANEOUS ASEPTIC NECROSIS DURING INTERFERON-ALPHA TREATMENT FOR CHRONIC MYELOGENOUS LEUKEMIA
    LEVESQUE, H
    CAILLEUX, N
    MOORE, N
    TILLY, H
    MONCONDUIT, M
    COURTOIS, H
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (06): : 582 - 583
12345